Market Research Logo

Cell and Gene Therapy Market - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Cell and Gene Therapy Market - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Cell therapy is the administration of living cells in patients for the treatment of a disease. The source of cell can be autologous or allogeneic, which can be derived from stem cells such as bone marrow. Stem cells therapy is used in bone marrow transplantation. Gene therapy is the introduction, removal, or change in the patient's genetic code for treatment of a disease. Moreover, it modifies the expression of an individual’s genes or repair abnormal genes. The therapy involves administration of nucleic acid (DNA/RNA) with carriers called as vectors.

Market Dynamics

Increasing prevalence of cancer diseases is a major factor driving the cell and gene therapy market growth. According to the World Cancer Research Funds and the American Institute for Cancer Research, in 2018, there were around 18 million cases of cancer, of which around 9.5 million were in men and around 8.5 million in women, globally. Moreover, introduction of innovative products and rich pipeline of cell and gene therapy is expected to boost the market growth. For instance, around 150 gene therapies are currently in the development stage. Gene replacement accounts for around two third of gene therapy pipeline. However, around 49% of gene therapies are under preclinical and discovery stages. During 2012-18, around 351 gene therapy deals were signed. For instance Gilead’s Kite Pharma received exclusive rights to Sangamo Therapeutics’ zinc finger nuclease gene editing technology, for $3.2bn.

Key features of the study:

  • This report provides in-depth analysis of the cell and gene therapy market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cell and gene therapy market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Amgen, Biogen, BioMarin Pharmaceuticals, Bristol-Myers Squibb Company, GlaxoSmithKline, Novartis, Pfizer, Regeneron Pharmaceuticals and Sanofi, Spark Therapeutics, Agilis Biotherapeutics, Angionetics AVROBIO, Freeline Therapeutics, Horama, MeiraGTx, Myonexus Therapeutics, Nightstar Therapeutics, Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., and MEDIPOST
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global cell and gene therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cell and gene therapy market
Detailed Segmentation:
  • Global Cell and Gene Therapy Market, By Therapy Type:
  • Cell Therapy
  • Stem Cells
  • T Cells
  • Dendritic Cells
  • NK Cells
  • Tumor Cells
  • Gene Therapy
  • Global Cell and Gene Therapy Market, By Indication:
  • Cardiovascular Disease
  • Cancer
  • Genetic Disorder
  • Infectious Disease
  • Neurological Disorders
  • Others
  • Global Cell and Gene Therapy Market, By Scale of Operation:
  • In House
  • Outsourced
  • Global Cell and Gene Therapy Market, By Geography:
  • North America
  • By Therapy Type:
  • Cell Therapy
  • Stem Cells
  • T Cells
  • Dendritic Cells
  • NK Cells
  • Tumor Cells
  • Gene Therapy
  • By Indication:
  • Cardiovascular Disease
  • Cancer
  • Genetic Disorder
  • Infectious Disease
  • Neurological Disorders
  • Others
  • By Scale of Operation:
  • In House
  • Outsourced
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Therapy Type:
  • Cell Therapy
  • Stem Cells
  • T Cells
  • Dendritic Cells
  • NK Cells
  • Tumor Cells
  • Gene Therapy
  • By Indication:
  • Cardiovascular Disease
  • Cancer
  • Genetic Disorder
  • Infectious Disease
  • Neurological Disorders
  • Others
  • By Scale of Operation:
  • In House
  • Outsourced
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Therapy Type:
  • Cell Therapy
  • Stem Cells
  • T Cells
  • Dendritic Cells
  • NK Cells
  • Tumor Cells
  • Gene Therapy
  • By Indication:
  • Cardiovascular Disease
  • Cancer
  • Genetic Disorder
  • Infectious Disease
  • Neurological Disorders
  • Others
  • By Scale of Operation:
  • In House
  • Outsourced
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Therapy Type:
  • Cell Therapy
  • Stem Cells
  • T Cells
  • Dendritic Cells
  • NK Cells
  • Tumor Cells
  • Gene Therapy
  • By Indication:
  • Cardiovascular Disease
  • Cancer
  • Genetic Disorder
  • Infectious Disease
  • Neurological Disorders
  • Others
  • By Scale of Operation:
  • In House
  • Outsourced
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Therapy Type:
  • Cell Therapy
  • Stem Cells
  • T Cells
  • Dendritic Cells
  • NK Cells
  • Tumor Cells
  • Gene Therapy
  • By Indication:
  • Cardiovascular Disease
  • Cancer
  • Genetic Disorder
  • Infectious Disease
  • Neurological Disorders
  • Others
  • By Scale of Operation:
  • In House
  • Outsourced
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Therapy Type:
  • Cell Therapy
  • Stem Cells
  • T Cells
  • Dendritic Cells
  • NK Cells
  • Tumor Cells
  • Gene Therapy
  • By Indication:
  • Cardiovascular Disease
  • Cancer
  • Genetic Disorder
  • Infectious Disease
  • Neurological Disorders
  • Others
  • By Scale of Operation:
  • In House
  • Outsourced
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Amgen *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • Biogen
  • BioMarin Pharmaceuticals
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • Regeneron Pharmaceuticals and Sanofi
  • Spark Therapeutics
  • Agilis Biotherapeutics
  • Angionetics AVROBIO
  • Freeline Therapeutics
  • Horama
  • MeiraGTx
  • Myonexus Therapeutics
  • Nightstar Therapeutics
  • Kolon TissueGene, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • MEDIPOST
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Therapy Type
Market Snippet, By Indication
Market Snippet, By Scale of Operation
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Diagnostic Algorithm
Pipeline Analysis
Reimbursement Scenario
Epidemiology
Pest Analysis
4. Global Cell and Gene Therapy Market, By Therapy Type, 2018 – 2026, (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Cell Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Stem Cells
T Cells
Dendritic Cells
NK Cells
Tumor Cells
Gene Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
5. Global Cell and Gene Therapy Market, By Indication, 2018 – 2026, (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Cardiovascular Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Genetic Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Infectious Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Neurological Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
6. Global Cell and Gene Therapy Market, By Scale of Operation, 2018 – 2026, (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
In-house
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
Outsourced
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
7. Global Cell and Gene Therapy Market, By Region, 2018 – 2026, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2026
North America
Market Size and Forecast, By Therapy Type, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Scale of Operation, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Therapy Type, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Scale of Operation, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Therapy Type, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Scale of Operation, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Therapy Type, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Scale of Operation, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Therapy Type, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Scale of Operation, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Therapy Type, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Indication, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Scale of Operation, 2016 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
South Africa
Central Africa
North Africa
8. Competitive Landscape
Heat Map Analysis
Company Profiles
Amgen
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Biogen
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
BioMarin Pharmaceuticals
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Bristol-Myers Squibb Company
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
GlaxoSmithKline
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Novartis
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Pfizer
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Regeneron Pharmaceuticals and Sanofi
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Spark Therapeutics
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Agilis Biotherapeutics
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Angionetics AVROBIO
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Freeline Therapeutics
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Horama
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
MeiraGTx
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Myonexus Therapeutics
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Nightstar Therapeutics
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Kolon TissueGene, Inc.
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
JCR Pharmaceuticals Co., Ltd.
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
MEDIPOST
Company Overview
Therapy Type Portfolio
Financial Overview
Key Highlights
Market Strategies
Analyst Views
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 35 market data tables and 28 figures on "Cell and Gene Therapy Market - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report